Needlestick Safety Injection Devices Market to Rise Rapidly; Increasing Focus on Safe Delivery of Healthcare Services to Propel the Market: Fortune Business Insights™ The global needlestick safety injection devices market size is set to enter a period of prolific expansionon account of the growing incidence of needlestick injuries (NSIs) among healthcare workers, observes Fortune Business Insights™ in its report, titled “Needlestick Safety Injection Devices Market Size, Share & Industry Analysis, By Type (Safety Syringe, Safety Needles), By End-User (Hospitals, Specialty Clinics, Ambulatory Surgical Centres, Diagnostic Centres, Others) and Regional Forecast, 2019-2026”. NSIs are a common phenomenon in healthcare facilities where doctors and nurses are constantly administering medications to patients through injections. These injuries, however, are dangerous as they may lead to life-altering infections such as HIV/AIDS and hepatitis B. The prevalence of NSIs has been consistently high around the world. For example, in the US, the Centers for Disease Control and Prevention (CDC) estimates that over 3 million healthcare workers are exposed to body fluids and blood via sharps injuries, with an annual incidence of NSIs standing at 6 million. Similarly, in the UK, a 2019 survey conducted by the medical solutions company, Mölnlycke, found that around 94% of practicing surgeons in the UK have either been afflicted by an NSI or have seen a colleague experience one. Thus, the awareness of the risks associated with these injuries is fueling the demand for needlestick safety injection devices in the healthcare sector. https://www.fortunebusinessinsights.com/enquiry/sample/needlestick-safety-injection-devices-market-103119 Competitive Landscape Major companies in the Global Needlestick Safety Injection Devices Market are increasingly focusing on research and development activities to create new and innovative products to stay ahead of the competition. Staying on top of market trends & drivers is crucial for decision-makers to hold this emerging opportunity. The study provides information on market trends and development, drivers, capacities, technologies, and the changing investment structure of the Needlestick Safety Injection DevicesIndustry. Industry-Government Partnerships to Battle COVID-19 to Heat up Competition The coronavirus pandemic has exerted tremendous stress on the healthcare sector across countries, impelling governments and industry players to collaborate and pool resources to fight this crisis. Apart from this, companies are focusing on developing and regularly launching innovative products to gain competitive edge. Industry Developments: July 2020: Smiths Medical joined forces with the US Health Department’s Biomedical Advanced Research and Development Authority and the Department of Defense. The aim of this venture is to expand the production of integrated hypodermic needles and syringes at the Smiths Medical Facility in New Hampshire to aid the government’s COVID vaccination efforts. September 2019:Gerresheimerannounced the expansion of its pre-fillable polymer syringe line with the addition of the Gx RTF® ClearJect®, 2.25 ml.The new offering is designed to suit the primary packaging needs of sophisticated medications, especially for biologicals, biosimilars, and biobetters. List of Key Players Covered in the Needlestick Safety Injection Devices Market Report: Catalent, Inc. DuoprossMeditech Corp Gerresheimer AG Smiths Group plc Medical Information Technology, Inc. Terumo Medical Corporation West Pharmaceutical Services, Inc. Medtronic